Cargando…
Adiponectin Trajectories Before Type 2 Diabetes Diagnosis: Whitehall II study
OBJECTIVE: The role of adiponectin in the natural history of diabetes is not well characterized. We set out to characterize prediagnosis trajectories of adiponectin in individuals who develop type 2 diabetes. RESEARCH DESIGN AND METHODS: In a case-cohort study (335 incident diabetes case and 2,474 n...
Autores principales: | Tabák, Adam G., Carstensen, Maren, Witte, Daniel R., Brunner, Eric J., Shipley, Martin J., Jokela, Markus, Roden, Michael, Kivimäki, Mika, Herder, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507593/ https://www.ncbi.nlm.nih.gov/pubmed/22933430 http://dx.doi.org/10.2337/dc11-2263 |
Ejemplares similares
-
Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study
por: Carstensen, Maren, et al.
Publicado: (2010) -
Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study
por: Hansen, Christian Stevns, et al.
Publicado: (2017) -
Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study
por: Vistisen, Dorte, et al.
Publicado: (2014) -
Determinants of Aortic Stiffness: 16-Year Follow-Up of the Whitehall II Study
por: Johansen, Nanna B., et al.
Publicado: (2012) -
Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985–2009
por: Hulmán, Adam, et al.
Publicado: (2014)